Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-10

FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

FDA granted a supplemental approval for the generic fixed-dose combination product valsartan and hydrochlorothiazide by Alembic Pharmaceuticals Limited. The pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Valsartan and Hydrochlorothiazide (Valsartan and Hydrochlorothiazide)

Snippet

SUPPL AP for VALSARTAN AND HYDROCHLOROTHIAZIDE (VALSARTAN AND HYDROCHLOROTHIAZIDE)